Skip to content
Screener

Lyell Immunopharma, Inc. LYEL Q1 2026 earnings

Reported May 6, 2026 · Before market open

Revenue$2.0KMiss by $1.0K
EPS-$1.10Beat by $1.68
Revenue estimate$3.0K
EPS estimate-$2.78

Next report

Nov 10, 2026 (in 2 months)
Revenue estimate$3.8K
EPS estimate-$2.06

FAQ

When did Lyell Immunopharma, Inc. report Q1 2026 earnings?
Lyell Immunopharma, Inc. (LYEL) reported Q1 2026 earnings on May 6, 2026 before market open.
What were Lyell Immunopharma, Inc.'s Q1 2026 revenue and EPS?
Lyell Immunopharma, Inc. reported revenue of $2.0K and eps of $-1.10 for Q1 2026.
Did Lyell Immunopharma, Inc. beat estimates in Q1 2026?
Revenue missed the consensus estimate of $3.0K by $1.0K. EPS beat the consensus estimate of $-2.78 by $1.68.
How did Lyell Immunopharma, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 71.4% from $7.0K a year earlier and eps grew 69.4% from $-3.60.
Where can I find Lyell Immunopharma, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001628280-26-031269) and the 10-Q periodic report (0001628280-26-031284) directly on SEC EDGAR. The filing index links above go to sec.gov.